Načítá se...
Vedolizumab therapy in common variable immune deficiency associated enteropathy: A case series
A number of gastrointestinal complications occur in common variable immunodeficiency (CVID). Infections are one cause, but various forms of severe non-infectious enteropathy also lead to substantial morbidity. The presence of T cell lymphocytic infiltrates in the mucosa have suggested that vedolizum...
Uloženo v:
| Vydáno v: | Clin Immunol |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7310569/ https://ncbi.nlm.nih.gov/pubmed/32058070 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clim.2020.108362 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|